OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
300535$19.7957

Sichuan Dowell Science and Technology Inc

Commodity ChemicalsVerified

Sichuan Dowell Science and Technology Inc maintains a debt-to-equity ratio of 0.29 and a current ratio of 1.46, indicating moderate liquidity and a conservative capital structure. The company's price-to-book ratio of 2.21 and price-to-tangible-book ratio of 2.21 suggest that the market values the company at a premium to its book value, while its price-to-earnings ratio of 59.14 and EV/EBITDA of 57.28 indicate a high valuation relative to earnings. Profitability metrics show a return on equity of 3.74% and a return on assets of 2.46%, both below the typical thresholds for high-performing chemical firms. The company's operating margin is 5.87% (calculated from operating income of 41.87 million CNY on revenue of 712.82 million CNY), which is lower than the median for the Commodity Chemicals industry. Gross margin of 39.07% (278.53 million CNY on 712.82 million CNY revenue) is in line with industry norms. The company's revenue is distributed across domestic and international markets, with notable exposure to Vietnam, Bangladesh, Ethiopia, Mongolia, and Thailand. However, the financial data does not provide a breakdown of revenue by region or segment, limiting visibility into geographic concentration risk. Growth prospects are constrained, with no specific revenue growth rates provided in the latest financials. The company reported a net income of 35.81 million CNY on revenue of 712.82 million CNY, with a free cash flow of -16.82 million CNY, indicating that capital expenditures of 89.54 million CNY exceeded operating cash flow of 70.81 million CNY. This suggests a capital-intensive business model with limited cash generation. The risk assessment highlights a medium liquidity risk due to negative net cash after subtracting total debt. Dilution risk is assessed as low, with no significant dilution sources identified in the latest filings. The company's capital structure remains stable, with long-term debt of 280.25 million CNY and total liabilities of 497.25 million CNY. Recent financial filings and transcripts do not indicate any material events or strategic shifts. The company's last actual EPS was 0.38 CNY, according to analyst estimates, which is consistent with the net income of 35.81 million CNY and 107.02 million shares outstanding.

30-day price · 300535-1.39 (-7.2%)
Low$17.80High$20.45Close$17.98As of15 May, 00:00 UTC
Profile
CompanySichuan Dowell Science and Technology Inc
Ticker300535.SZ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Sichuan Dowell Science and Technology Inc develops, produces, and sells leather chemicals, including enzyme preparations, degreasers, bactericidal mold inhibitors, and finishing materials, primarily for domestic and international markets such as Vietnam, Bangladesh, Ethiopia, Mongolia, and Thailand.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a confidence level of 0.92 based on verified market data.

Sichuan Dowell Science and Technology Inc maintains a debt-to-equity ratio of 0.29 and a current ratio of 1.46, indicating moderate liquidity and a conservative capital structure. The company's price-to-book ratio of 2.21 and price-to-tangible-book ratio of 2.21 suggest that the market values the company at a premium to its book value, while its price-to-earnings ratio of 59.14 and EV/EBITDA of 57.28 indicate a high valuation relative to earnings. Profitability metrics show a return on equity of 3.74% and a return on assets of 2.46%, both below the typical thresholds for high-performing chemical firms. The company's operating margin is 5.87% (calculated from operating income of 41.87 million CNY on revenue of 712.82 million CNY), which is lower than the median for the Commodity Chemicals industry. Gross margin of 39.07% (278.53 million CNY on 712.82 million CNY revenue) is in line with industry norms. The company's revenue is distributed across domestic and international markets, with notable exposure to Vietnam, Bangladesh, Ethiopia, Mongolia, and Thailand. However, the financial data does not provide a breakdown of revenue by region or segment, limiting visibility into geographic concentration risk. Growth prospects are constrained, with no specific revenue growth rates provided in the latest financials. The company reported a net income of 35.81 million CNY on revenue of 712.82 million CNY, with a free cash flow of -16.82 million CNY, indicating that capital expenditures of 89.54 million CNY exceeded operating cash flow of 70.81 million CNY. This suggests a capital-intensive business model with limited cash generation. The risk assessment highlights a medium liquidity risk due to negative net cash after subtracting total debt. Dilution risk is assessed as low, with no significant dilution sources identified in the latest filings. The company's capital structure remains stable, with long-term debt of 280.25 million CNY and total liabilities of 497.25 million CNY. Recent financial filings and transcripts do not indicate any material events or strategic shifts. The company's last actual EPS was 0.38 CNY, according to analyst estimates, which is consistent with the net income of 35.81 million CNY and 107.02 million shares outstanding.
Key takeaways
  • Sichuan Dowell Science and Technology Inc has a high valuation multiple (P/E of 59.14, EV/EBITDA of 57.28) despite relatively low profitability (ROE of 3.74%, ROA of 2.46%).
  • The company's capital structure is conservative, with a debt-to-equity ratio of 0.29 and a current ratio of 1.46, but free cash flow is negative due to high capital expenditures.
  • Revenue is distributed across domestic and international markets, but the financial data does not provide a detailed breakdown of geographic exposure.
  • Growth is limited, with no specific revenue growth rates provided, and the company is capital-intensive with limited cash generation.
  • Liquidity risk is moderate, and dilution risk is low, with no significant dilution sources identified in the latest filings.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$712.8M
Gross profit$278.5M
Operating income$41.9M
Net income$35.8M
R&D
SG&A
D&A
SBC
Operating cash flow$70.8M
CapEx-$89.5M
Free cash flow-$16.8M
Total assets$1.45B
Total liabilities$497.3M
Total equity$957.6M
Cash & equivalents
Long-term debt$280.2M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$19.79
Market cap$2.12B
Enterprise value$2.40B
P/E59.1
Reported non-GAAP P/E
EV/Revenue3.4
EV/Op income57.3
EV/OCF33.9
P/B2.2
P/Tangible book2.2
Tangible book$957.6M
Net cash-$280.2M
Current ratio1.5
Debt/Equity0.3
ROA2.5%
ROE3.7%
Cash conversion2.0%
CapEx/Revenue-12.6%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric300535Activity
Op margin5.9%0.4% medp25 -8.0% · p75 16.0%above median
Net margin5.0%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin39.1%20.8% medp25 14.9% · p75 24.0%top quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-12.6%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity29.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Observations
IR observations
Last actual EPS0.38 CNY
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 15:26 UTC#bdf1953b
Market quoteclose CNY 19.79 · shares 0.11B diluted
no public URL
2026-05-04 15:26 UTC#aaf25c3a
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 15:27 UTCJob: c76504c1